Imaging amyloid deposition in Lewy body diseases.
BACKGROUND
Extrapyramidal motor symptoms precede dementia in Parkinson disease (PDD) by many years, whereas dementia occurs early in dementia with Lewy bodies (DLB). Despite this clinical distinction, the neuropsychological and neuropathologic features of these conditions overlap. In addition to widespread distribution of Lewy bodies, both diseases have variable burdens of neuritic plaques and neurofibrillary tangles characteristic of Alzheimer disease (AD).


OBJECTIVE
To determine whether amyloid deposition, as assessed by PET imaging with the beta-amyloid-binding compound Pittsburgh Compound B (PiB), can distinguish DLB from PDD, and to assess whether regional patterns of amyloid deposition correlate with specific motor or cognitive features.


METHODS
Eight DLB, 7 PDD, 11 Parkinson disease (PD), 15 AD, and 37 normal control (NC) subjects underwent PiB-PET imaging and neuropsychological assessment. Amyloid burden was quantified using the PiB distribution volume ratio.


RESULTS
Cortical amyloid burden was higher in the DLB group than in the PDD group, comparable to the AD group. Amyloid deposition in the PDD group was low, comparable to the PD and NC groups. Relative to global cortical retention, occipital PiB retention was lower in the AD group than in the other groups. For the DLB, PDD, and PD groups, amyloid deposition in the parietal (lateral and precuneus)/posterior cingulate region was related to visuospatial impairment. Striatal PiB retention in the DLB and PDD groups was associated with less impaired motor function.


CONCLUSIONS
Global cortical amyloid burden is high in dementia with Lewy bodies (DLB) but low in Parkinson disease dementia. These data suggest that beta-amyloid may contribute selectively to the cognitive impairment of DLB and may contribute to the timing of dementia relative to the motor signs of parkinsonism.
Gomperts
S N
SN
Massachusetts General Hospital, Boston, MA 02114, USA.
Rentz
D M
DM
Moran
E
E
Becker
J A
JA
Locascio
J J
JJ
Klunk
W E
WE
Mathis
C A
CA
Elmaleh
D R
DR
Shoup
T
T
Fischman
A J
AJ
Hyman
B T
BT
Growdon
J H
JH
Johnson
K A
KA
D000368:Aged; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000814:Aniline Compounds; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism*; D003071:Cognition; D003704:Dementia / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000378:metabolism*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D020961:Lewy Body Disease / Q000503:physiopathology / Q000523:psychology*; D008297:Male; D008875:Middle Aged; D009068:Movement; D009483:Neuropsychological Tests; D010300:Parkinson Disease / Q000503:physiopathology / Q000523:psychology*; D049268:Positron-Emission Tomography; D013844:Thiazoles; D014018:Tissue Distribution
C475519:2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole; D016229:Amyloid beta-Peptides; D000814:Aniline Compounds; D013844:Thiazoles
Eur J Neurol. 2007 Dec;14(12):1357-62
17941855
Br J Psychiatry. 1982 Jun;140:566-72
7104545
J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
8784228
J Neurosci. 2007 Jun 6;27(23):6174-84
17553989
Neuroimage. 2008 Feb 1;39(3):1027-33
18035558
Neurology. 1984 Jul;34(7):939-44
6610841
Neurology. 2007 May 15;68(20):1718-25
17502554
Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837
17542011
J Nucl Med. 2005 Dec;46(12):1959-72
16330558
J Neurosci. 2007 Sep 26;27(39):10365-71
17898208
Neurology. 1988 Jun;38(6):900-3
3368071
J Neural Transm Park Dis Dement Sect. 1990;2(1):45-57
2357270
Ann Neurol. 2007 Sep;62(3):229-34
17683091
Ann Neurol. 1999 Mar;45(3):358-68
10072051
J Neurosci. 2003 Mar 15;23(6):2086-92
12657667
Acta Neuropathol. 1998 Jun;95(6):576-82
9650749
Ann Neurol. 2006 Jul;60(1):145-7
16802294
Neurology. 2007 Mar 13;68(11):812-9
17353469
Arch Neurol. 1993 Feb;50(2):140-8
8431132
Brain. 2007 Oct;130(Pt 10):2607-15
17698496
Neurol Clin. 2000 Nov;18(4):865-902
11072265
Ann Neurol. 2006 Mar;59(3):512-9
16372280
J Med Chem. 2003 Jun 19;46(13):2740-54
12801237
Ann Neurol. 2008 Jan;63(1):112-8
18023012
Neuroimage. 2002 Jan;15(1):273-89
11771995
Neurology. 2000 Jan 25;54(2):407-11
10668703
Acta Neuropathol. 2001 Oct;102(4):355-63
11603811
Neurology. 2004 Jan 27;62(2):181-7
14745051
Neurology. 2007 Feb 13;68(7):501-8
17065593
J Geriatr Psychiatry Neurol. 2004 Sep;17(3):137-45
15312277
J Neural Transm (Vienna). 2003 Jul;110(7):771-8
12811637
Brain. 2007 Nov;130(Pt 11):2837-44
17928318
Neurology. 1994 Dec;44(12):2308-14
7991117
Neurology. 2005 Dec 27;65(12):1863-72
16237129
Neurology. 2006 Aug 8;67(3):446-52
16894106
Neurology. 2006 Jun 27;66(12):1837-44
16801647
Arch Neurol. 2007 Mar;64(3):431-4
17353389
Mov Disord. 2003 Jan;18(1):81-6
12518303
Acta Neuropathol. 2006 Sep;112(3):253-60
16804711